20.37
전일 마감가:
$20.27
열려 있는:
$20.4
하루 거래량:
319.03K
Relative Volume:
1.12
시가총액:
$771.46M
수익:
$89.06M
순이익/손실:
$-53.41M
주가수익비율:
-13.94
EPS:
-1.4612
순현금흐름:
$-42.48M
1주 성능:
-2.07%
1개월 성능:
+9.69%
6개월 성능:
+72.92%
1년 성능:
+25.90%
Ceribell Inc Stock (CBLL) Company Profile
명칭
Ceribell Inc
전화
(800) 436-0826
주소
360 N. PASTORIA AVENUE, SUNNYVALE
Compare CBLL vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
CBLL
Ceribell Inc
|
20.37 | 767.68M | 89.06M | -53.41M | -42.48M | -1.4612 |
|
ABT
Abbott Laboratories
|
87.17 | 152.48B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
295.25 | 111.40B | 25.27B | 3.34B | 4.57B | 8.6358 |
|
MDT
Medtronic Plc
|
77.79 | 100.53B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
55.98 | 84.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
82.91 | 48.04B | 6.30B | 1.07B | 1.34B | 1.8406 |
Ceribell Inc Stock (CBLL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-21 | 개시 | Raymond James | Strong Buy |
| 2025-06-24 | 개시 | BTIG Research | Buy |
| 2025-04-04 | 개시 | Ladenburg Thalmann | Buy |
| 2024-11-05 | 개시 | BofA Securities | Buy |
| 2024-11-05 | 개시 | Canaccord Genuity | Buy |
| 2024-11-05 | 개시 | JP Morgan | Overweight |
| 2024-11-05 | 개시 | TD Cowen | Buy |
| 2024-11-05 | 개시 | William Blair | Outperform |
모두보기
Ceribell Inc 주식(CBLL)의 최신 뉴스
Insider sells 78,000 CBLL shares and 2,084 more (CBLL) - Stock Titan
Ceribell CTO Raymond Woo sells $226,928 of CBLL common stock By Investing.com - Investing.com Australia
Ceribell CTO Raymond Woo sells $226,928 of CBLL common stock - Investing.com
Ceribell (NASDAQ: CBLL) CTO sells shares under 10b5-1 trading plan - Stock Titan
CBLL (CBLL) Form 144 shows option-based sales and recent insider disposals - Stock Titan
CeriBell, Inc. (NASDAQ:CBLL) Sees Significant Decrease in Short Interest - MarketBeat
CeriBell (NASDAQ:CBLL) Stock Price Down 8.1%Should You Sell? - MarketBeat
Ceribell to Participate in the Bank of America Securities 2026 Health Care Conference - The Manila Times
Ceribell CEO, CFO to speak at Bank of America health conference - Stock Titan
Protara, Ceribell rise on FDA breakthrough designations - MSN
CeriBell, Inc.Common Stock (Nasdaq:CBLL) Stock Quote - FinancialContent
CeriBell a new buy at BTIG on growth in EEG monitoring system - MSN
CBLL Price Today: CeriBell, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
CBLL (CeriBell) reports narrower Q4 2025 loss than expected, as shares dip 0.85% in daily trading.Earnings Forecast - Cổng thông tin điện tử tỉnh Lào Cai
CeriBell (CBLL) Future Plans | CeriBell Inc. beats EPS estimates by 14.4% on narrower lossReceivables Turnover - Cổng thông tin điện tử tỉnh Tây Ninh
CeriBell (CBLL) Stock Interest Rate (+2.41%) 2026-04-22Professional Trade Ideas - Cổng thông tin điện tử tỉnh Lào Cai
CeriBell, Inc. (NASDAQ:CBLL) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Ceribell to Report First Quarter 2026 Financial Results on May 11, 2026 - The Manila Times
Ceribell, Inc. ($CBLL) President, CEO, and Co-Founder 2025 Pay Revealed - Quiver Quantitative
Ceribell sets May 11 investor call for first-quarter results - Stock Titan
Ceribell | ARS: Annual Report to Security Holders - Moomoo
CeriBell (CBLL) Stock: Price Structure Insight (-0.52%) 2026-04-20Cycle Analysis - Xã Thanh Hà
[ARS] Ceribell, Inc. SEC Filing - Stock Titan
CeriBell (NASDAQ: CBLL) details 2026 virtual meeting, board votes and pay - Stock Titan
Ceribell, Inc. unveils AI-powered EEG platform for neurologists at AAN2026 - Traders Union
Robertson sells Ceribell (CBLL) shares worth $14,720 - Investing.com
Analysts Offer Insights on Healthcare Companies: Ceribell, Inc. (CBLL), ANI Pharmaceuticals (ANIP) and Amylyx Pharmaceuticals Inc (AMLX) - The Globe and Mail
CeriBell, Inc. (CBLL) Stock Analysis: Analysts See 32.94% Upside Potential In Innovative Medical Technology - DirectorsTalk Interviews
CCORF Maintains Ceribell(CBLL.US) With Buy Rating, Maintains Target Price $28 - 富途牛牛
Ceribell Targets ICU Delirium With New EEG Study, Signaling Wider Market Ambitions - TipRanks
Rapid point-of-care EEG gives clinicians real-time diagnosis options, Ceribell, Inc. argues - Traders Union
Ceribell stock gets CMS proposal for new tech add-on payment - Investing.com Canada
TD Cowen Maintains Ceribell(CBLL.US) With Buy Rating, Maintains Target Price $29 - Moomoo
Fundamentals Check: Is CeriBell Inc a top pick in the sector2026 News Drivers & Precise Swing Trade Alerts - baoquankhu1.vn
Ceribell, Inc. promotes point of care EEG for adherence to ACNS neonatal seizure guidelines - Traders Union
Aug Catalysts: Is CeriBell Inc a top pick in the sector2026 Performance Recap & Stepwise Trade Signal Implementation - baoquankhu1.vn
Ceribell, Inc. webinar promotes point of care EEG use in critical care - Traders Union
Valuation Update: How sensitive is CeriBell Inc to inflationStock Surge & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Ideas Watch: What are the future prospects of CeriBell IncPrice Action & Comprehensive Market Scan Insights - baoquankhu1.vn
Ceribell: Chao Xingjuan sells $717k in shares By Investing.com - Investing.com Australia
Aug PostEarnings: What is CeriBell Incs 5 year growth outlookTrade Performance Summary & Growth Focused Entry Reports - baoquankhu1.vn
Xingjuan Chao Sells 39,000 Shares of CeriBell (NASDAQ:CBLL) Stock - MarketBeat
Ceribell: Chao Xingjuan sells $717k in shares - Investing.com UK
Ceribell Insider Sold Shares Worth $717,600, According to a Recent SEC Filing - marketscreener.com
Ceribell (CBLL) CEO trades 39K shares under 10b5-1 plan - Stock Titan
Quarterly Risk: How sensitive is CeriBell Inc to inflation2026 Price Swings & Daily Growth Stock Investment Tips - baoquankhu1.vn
Ceribell Inc (CBLL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):